Answers are grounded in this paper and cite their sources.
Conclusion The interventional radiologist should understand NSS and the current state of the art in the management of clinical stage 1 renal masses. As outlined in most clinical guidelines, NSS is the treatment of choice for the SRM in a healthy patient. Patient selection and preoperative preparation are critical for successful outcomes with NSS. RMB has a role, but has a nondiagnostic rate of around 10% as well as a NPV of only 75%, which cannot eliminate follow-up. Observation and ablation are reasonable treatment alternatives in the well-counseled patient.
No takes yet. Share an insight, caveat, or question.
Moss et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: